<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Cerus Corporation — News on 6ix</title>
<link>https://6ix.com/company/cerus-corporation</link>
<description>Latest news and press releases for Cerus Corporation on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 27 Apr 2026 12:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/cerus-corporation" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835541478dffbe2df0e8bd1.webp</url>
<title>Cerus Corporation</title>
<link>https://6ix.com/company/cerus-corporation</link>
</image>
<item>
<title>Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System</title>
<link>https://6ix.com/company/cerus-corporation/news/cerus-corporation-announces-new-four-year-supply-agreement-with-french-blood-establishment-for-intercept-blood-system</link>
<guid isPermaLink="true">https://6ix.com/company/cerus-corporation/news/cerus-corporation-announces-new-four-year-supply-agreement-with-french-blood-establishment-for-intercept-blood-system</guid>
<pubDate>Mon, 27 Apr 2026 12:00:00 GMT</pubDate>
<description>CONCORD, Calif., April 27, 2026--Cerus Corporation (Nasdaq: CERS) announced today the signing of a new, four-year supply agreement with Établissement Français du Sang (EFS), the French Blood Establishment, for the INTERCEPT Blood System. The agreement covers the INTERCEPT Blood System for platelets and plasma as well as the next generation, LED-based INT200 illumination device.</description>
</item>
<item>
<title>Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026</title>
<link>https://6ix.com/company/cerus-corporation/news/cerus-corporation-to-release-first-quarter-2026-financial-results-on-april-30-2026</link>
<guid isPermaLink="true">https://6ix.com/company/cerus-corporation/news/cerus-corporation-to-release-first-quarter-2026-financial-results-on-april-30-2026</guid>
<pubDate>Thu, 16 Apr 2026 20:01:00 GMT</pubDate>
<description>CONCORD, Calif., April 16, 2026--Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2026 financial results will be released on Thursday, April 30, 2026, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company’s financial results and provide a general business overview and outlook.</description>
</item>
<item>
<title>Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer</title>
<link>https://6ix.com/company/cerus-corporation/news/cerus-appoints-vivek-jayaraman-as-president-and-chief-executive-officer</link>
<guid isPermaLink="true">https://6ix.com/company/cerus-corporation/news/cerus-appoints-vivek-jayaraman-as-president-and-chief-executive-officer</guid>
<pubDate>Mon, 16 Mar 2026 20:05:00 GMT</pubDate>
<description>CONCORD, Calif., March 16, 2026--Cerus Corporation (Nasdaq: CERS) today announced that Vivek Jayaraman, Cerus’ chief operating officer, will be promoted to president and chief executive officer, effective July 1, 2026. William "Obi" Greenman will become executive chairman of the board of directors. At the time of his appointment, Mr. Jayaraman will join the Board of Directors.</description>
</item>
<item>
<title>Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/cerus-corporation/news/cerus-corporation-announces-full-year-and-fourth-quarter-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/cerus-corporation/news/cerus-corporation-announces-full-year-and-fourth-quarter-2025-financial-results</guid>
<pubDate>Mon, 02 Mar 2026 21:01:00 GMT</pubDate>
<description>CONCORD, Calif., March 02, 2026--Cerus Corporation (Nasdaq: CERS) announced today financial results for its full year and fourth quarter ended December 31, 2025.</description>
</item>
<item>
<title>Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference</title>
<link>https://6ix.com/company/cerus-corporation/news/cerus-corporation-to-participate-in-the-td-cowen-46th-annual-health-care-conference</link>
<guid isPermaLink="true">https://6ix.com/company/cerus-corporation/news/cerus-corporation-to-participate-in-the-td-cowen-46th-annual-health-care-conference</guid>
<pubDate>Fri, 20 Feb 2026 13:30:00 GMT</pubDate>
<description>CONCORD, Calif., February 20, 2026--Cerus Corporation (Nasdaq: CERS) announced today that members of the Company’s management are scheduled to present at the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026, at 10:30 a.m. EST.</description>
</item>
<item>
<title>Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026</title>
<link>https://6ix.com/company/cerus-corporation/news/cerus-corporation-release-fourth-quarter-210100913</link>
<guid isPermaLink="true">https://6ix.com/company/cerus-corporation/news/cerus-corporation-release-fourth-quarter-210100913</guid>
<pubDate>Tue, 17 Feb 2026 21:01:00 GMT</pubDate>
<description>CONCORD, Calif., February 17, 2026--Cerus Corporation (Nasdaq: CERS) announced today its fourth quarter and full-year 2025 financial results will be released on Monday, March 2, 2026, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET, during which management will discuss the Company’s financial results and provide a general business overview and outlook.</description>
</item>
<item>
<title>DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus’ INTERCEPT™ Blood System in Routine Clinical Practice</title>
<link>https://6ix.com/company/cerus-corporation/news/drk-blood-donation-baden-w-123000602</link>
<guid isPermaLink="true">https://6ix.com/company/cerus-corporation/news/drk-blood-donation-baden-w-123000602</guid>
<pubDate>Thu, 22 Jan 2026 12:30:00 GMT</pubDate>
<description>CONCORD, Calif., January 22, 2026--Cerus Corporation (Nasdaq: CERS) today announced the start of the INITIATE study by the German Red Cross Blood Donation Service Baden-Württemberg – Hessen and its subsidiary organization, the German Red Cross Blood Donation Service North-East. The prospective, multicenter, non-interventional safety study, sponsored by DRK Blood Donation Service Baden-Württemberg-Hessen, is the first of its kind in Germany to evaluate the routine use of pathogen-inactivated plat</description>
</item>
<item>
<title>Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook</title>
<link>https://6ix.com/company/cerus-corporation/news/cerus-corporation-announces-preliminary-fourth-quarter-and-full-year-2025-product</link>
<guid isPermaLink="true">https://6ix.com/company/cerus-corporation/news/cerus-corporation-announces-preliminary-fourth-quarter-and-full-year-2025-product</guid>
<pubDate>Sun, 11 Jan 2026 05:00:00 GMT</pubDate>
<description>Preliminary Full-Year 2025 Product Revenue of $206.1 Million Full-Year 2026 Product Revenue Expected to be $224 Million to $228 Million, Reflecting 9%-11%</description>
</item>
<item>
<title>Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America</title>
<link>https://6ix.com/company/cerus-corporation/news/cerus-corporation-announces-group-purchasing-agreement-blood-centers-america-2025-12</link>
<guid isPermaLink="true">https://6ix.com/company/cerus-corporation/news/cerus-corporation-announces-group-purchasing-agreement-blood-centers-america-2025-12</guid>
<pubDate>Wed, 10 Dec 2025 05:00:00 GMT</pubDate>
<description>CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) announced today that it has entered into a group purchasing agreement with Blood Centers</description>
</item>
<item>
<title>Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance</title>
<link>https://6ix.com/company/cerus-corporation/news/cerus-corporation-announces-record-results-third-quarter-2025-and-raises-full-year</link>
<guid isPermaLink="true">https://6ix.com/company/cerus-corporation/news/cerus-corporation-announces-record-results-third-quarter-2025-and-raises-full-year</guid>
<pubDate>Thu, 06 Nov 2025 05:00:00 GMT</pubDate>
<description>Third Quarter Total Revenue up 19% to $60.2 Million; Record Product Revenue of $52.7 Million, Up 15% Year-Over-Year Raising Full-Year 2025 Product Revenue</description>
</item>
<item>
<title>Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting</title>
<link>https://6ix.com/company/cerus-corporation/news/cerus-corporation-announces-abstracts-and-industry-workshop-ifc-2025-aabb-annual</link>
<guid isPermaLink="true">https://6ix.com/company/cerus-corporation/news/cerus-corporation-announces-abstracts-and-industry-workshop-ifc-2025-aabb-annual</guid>
<pubDate>Tue, 21 Oct 2025 04:00:00 GMT</pubDate>
<description>CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) announced today that it will host an industry workshop on the benefits of Pathogen</description>
</item>
<item>
<title>Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025</title>
<link>https://6ix.com/company/cerus-corporation/news/cerus-corporation-release-third-quarter-2025-financial-results-november-6-2025-2025</link>
<guid isPermaLink="true">https://6ix.com/company/cerus-corporation/news/cerus-corporation-release-third-quarter-2025-financial-results-november-6-2025-2025</guid>
<pubDate>Thu, 16 Oct 2025 04:00:00 GMT</pubDate>
<description>CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) announced today that its third quarter 2025 financial results will be released on</description>
</item>
<item>
<title>The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions</title>
<link>https://6ix.com/company/cerus-corporation/news/german-national-blood-advisory-committee-130000258</link>
<guid isPermaLink="true">https://6ix.com/company/cerus-corporation/news/german-national-blood-advisory-committee-130000258</guid>
<pubDate>Mon, 25 Aug 2025 13:00:00 GMT</pubDate>
<description>CONCORD, Calif., August 25, 2025--Cerus Corporation (Nasdaq: CERS) announced today the publication of a new recommendation from the German National Blood Advisory Committee (Arbeitskreis Blut or AK Blut), which recommends proactive measures, including pathogen inactivation (PI) such as INTERCEPT®, as core measures to enhance the safety of platelet transfusions. AK Blut is an expert committee that advises the German federal authorities on the safety of blood, blood products, and cells for transfu</description>
</item>
<item>
<title>Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025</title>
<link>https://6ix.com/company/cerus-corporation/news/cerus-corporation-participate-cantor-global-healthcare-conference-2025-2025-08-21</link>
<guid isPermaLink="true">https://6ix.com/company/cerus-corporation/news/cerus-corporation-participate-cantor-global-healthcare-conference-2025-2025-08-21</guid>
<pubDate>Thu, 21 Aug 2025 04:00:00 GMT</pubDate>
<description>CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) announced today that company management will participate in a fireside chat at the Cantor</description>
</item>
<item>
<title>Cerus Corporation Announces Second Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/cerus-corporation/news/cerus-corporation-announces-second-quarter-2025-financial-results-2025-08-07</link>
<guid isPermaLink="true">https://6ix.com/company/cerus-corporation/news/cerus-corporation-announces-second-quarter-2025-financial-results-2025-08-07</guid>
<pubDate>Tue, 05 Aug 2025 04:00:00 GMT</pubDate>
<description>Second Quarter Total Revenue of $60.1 Million; Record Product Revenue of $52.4 Million, Up 16% Year-Over-Year Raising Full-Year 2025 Product Revenue Guidance</description>
</item>
<item>
<title>Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025</title>
<link>https://6ix.com/company/cerus-corporation/news/cerus-corporation-release-second-quarter-2025-financial-results-august-5-2025-2025-07</link>
<guid isPermaLink="true">https://6ix.com/company/cerus-corporation/news/cerus-corporation-release-second-quarter-2025-financial-results-august-5-2025-2025-07</guid>
<pubDate>Tue, 22 Jul 2025 04:00:00 GMT</pubDate>
<description>CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) announced today that its second quarter 2025 financial results will be released on</description>
</item>
<item>
<title>Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury</title>
<link>https://6ix.com/company/cerus-corporation/news/cerus-corporation-announces-additional-department-defense-award-advance-care-major</link>
<guid isPermaLink="true">https://6ix.com/company/cerus-corporation/news/cerus-corporation-announces-additional-department-defense-award-advance-care-major</guid>
<pubDate>Mon, 21 Jul 2025 04:00:00 GMT</pubDate>
<description>Additional Funding to Support Randomized Study Evaluating Earlier Access to INTERCEPT Fibrinogen Complex in Trauma Associated Hemorrhagic Shock Patients</description>
</item>
<item>
<title>Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update</title>
<link>https://6ix.com/company/cerus-corporation/news/cerus-corporation-provides-intercept-red-blood-cell-ce-mark-application-update-2025</link>
<guid isPermaLink="true">https://6ix.com/company/cerus-corporation/news/cerus-corporation-provides-intercept-red-blood-cell-ce-mark-application-update-2025</guid>
<pubDate>Wed, 02 Jul 2025 04:00:00 GMT</pubDate>
<description>Cerus’ Notified Body, TÜV-SÜD, has completed the review of the clinical module for the CE Mark submission for INTERCEPT Red Blood Cells (RBCs) CONCORD,</description>
</item>
<item>
<title>Cerus Corporation Celebrates World Blood Donor Day 2025</title>
<link>https://6ix.com/company/cerus-corporation/news/cerus-corporation-celebrates-world-blood-donor-day-2025-2025-06-13</link>
<guid isPermaLink="true">https://6ix.com/company/cerus-corporation/news/cerus-corporation-celebrates-world-blood-donor-day-2025-2025-06-13</guid>
<pubDate>Fri, 13 Jun 2025 04:00:00 GMT</pubDate>
<description>CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) is proud to announce its celebration of World Blood Donor Day 2025. In 2005, the World</description>
</item>
<item>
<title>Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025</title>
<link>https://6ix.com/company/cerus-corporation/news/cerus-corporation-participate-goldman-sachs-46th-annual-global-healthcare-conference</link>
<guid isPermaLink="true">https://6ix.com/company/cerus-corporation/news/cerus-corporation-participate-goldman-sachs-46th-annual-global-healthcare-conference</guid>
<pubDate>Tue, 03 Jun 2025 04:00:00 GMT</pubDate>
<description>CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) announced today that members of the management team are scheduled to present at the</description>
</item>
</channel>
</rss>